Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market : NYSE Euronext Paris
ISIN Code: FR 0010417345
Date | Total number of shares | Total number of voting rights |
05/31/2024 | 96,493,078 | Total gross of voting rights: 96,493,078 |
Total net* of voting rights: 96,236,383 |
* Net total = total number of voting rights attached to shares – shares without voting rights
Last Trade: | US$10.83 |
Daily Change: | -0.16 -1.46 |
Daily Volume: | 2,574 |
Market Cap: | US$296.310M |
January 08, 2025 |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORETerns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREEnd of content
No more pages to load